MEF2A regulates Calpain 3 expression in L6 myoblasts

Area of Science:

• Muscle biology
• Molecular genetics
• Enzymology

Background:

• Calpain 3 (Capn3) is a skeletal muscle protease with known non-proteolytic functions.
• Capn3 expression correlates with muscle atrophy and influences myoblast differentiation.
• Transcriptional regulation of Capn3 remains largely uncharacterized.

Purpose of the Study:

• To investigate the transcriptional regulation of the Capn3 gene.
• To identify transcription factors that control Capn3 gene expression.

Main Methods:

• Luciferase reporter assays and electrophoretic mobility shift assays (EMSA) to assess promoter binding.
• Quantitative real-time PCR (qRT-PCR), Western blotting, and immunocytochemistry in L6 myoblasts.
• Small interfering RNA (siRNA) knockdown of Mef2a in L6 myoblasts.
• Chromatin immunoprecipitation (ChIP) in rat denervated gastrocnemius muscle.

Main Results:

• Myogenic enhancer factor 2A (MEF2A) was identified as a regulator of Capn3.
• MEF2A binds to the Capn3 promoter region.
• Capn3 expression is positively correlated with MEF2A levels in differentiating L6 myoblasts.
• MEF2A knockdown reduces Capn3 protein levels.
• MEF2A occupies the Capn3 promoter in vivo in denervated muscle.

Conclusions:

• MEF2A acts as a transcriptional regulator of the Capn3 gene.
• This finding elucidates a key mechanism in the regulation of Capn3 expression in skeletal muscle.
• Understanding MEF2A-Capn3 interaction may offer insights into muscle atrophy and differentiation processes.